Hantavirus Research in Finland
1. Introduction
2. Immune Response and Pathogenesis
3. Clinical Course
4. Epidemiology and Ecology
5. Treatment
6. Conclusions
Author Contributions
Conflicts of Interest
References
- Vaheri, A.; Henttonen, H.; Mustonen, J. Hantavirus research in Finland: Highlights and perspectives. Viruses 2021, 13, 1452. [Google Scholar] [CrossRef]
- Iheozor-Ejiofor, R.; Vapalahti, K.; Sironen, T.; Levanov, L.; Hepojoki, J.; Lundkvist, Å.; Mäkelä, S.; Vaheri, A.; Mustonen, J.; Plyusnin, A.; et al. Neutralizing antibody titers in hospitalized patients with acute Puumala orthohantavirus infection do not associate with disease severity. Viruses 2022, 14, 901. [Google Scholar] [CrossRef]
- Bharadwaj, M.; Nofchissey, R.; Goade, D.; Koster, F.; Hjelle, B. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J. Infect. Dis. 2000, 182, 43–48. [Google Scholar] [CrossRef] [PubMed]
- Cabrera, L.E.; Schmotz, C.; Saleem, M.A.; Lehtonen, S.; Vapalahti, O.; Vaheri, A.; Mäkelä, S.; Mustonen, J.; Strandin, T. Increased heparanase levels in urine during acute Puumala orthohantavirus infection are associated with disease severity. Viruses 2022, 14, 450. [Google Scholar] [CrossRef]
- Lamponen, T.; Hetemäki, I.; Niemi, H.J.; Jarva, H.; Kekäläinen, E.; Mäkelä, S.; Mustonen, J.; Vaheri, A.; Arstila, T.P. Heterologous boosting of nonrelated toxoid immunity during acute Puumala hantavirus infection. Vaccine 2021, 39, 1818–1825. [Google Scholar] [CrossRef]
- Hepojoki, J.; Cabrera, L.E.; Hepojoki, S.; Bellomo, C.; Kareinen, L.; Andersson, L.C.; Vaheri, A.; Mäkelä, S.; Mustonen, J.; Vapalahti, O.; et al. Hantavirus infection-induced B cell activation elevates free light chains levels in circulation. PLoS Pathog. 2021, 17, e1009843. [Google Scholar] [CrossRef]
- Vangeti, S.; Strandin, T.; Liu, S.; Tauriainen, J.; Räisänen-Sokolowski, A.; Cabrera, L.; Hassinen, A.; Mäkelä, S.; Mustonen, J.; Vaheri, A.; et al. Monocyte subset redistribution from blood to kidneys in patients with Puumala virus caused hemorrhagic fever with renal syndrome. PLoS Pathog. 2021, 17, e1009400. [Google Scholar] [CrossRef]
- Strandin, T.; Mäkelä, S.; Mustonen, J.; Vaheri, A. Neutrophil activation in acute hemorrhagic fever with renal syndrome is mediated by hantavirus-infected microvascular endothelial cells. Front. Immunol. 2018, 9, 2098. [Google Scholar] [CrossRef]
- Cabrera, L.E.; Tietäväinen, J.; Jokiranta, S.T.; Mäkelä, S.; Vaheri, A.; Mustonen, J.; Vapalahti, O.; Kanerva, M.; Strandin, T. Maturing neutrophils of lower density associate with thrombocytopenia in Puumala orthohantavirus-caused hemorrhagic fever with renal syndrome. Front. Immunol. 2024, 15, 1419787. [Google Scholar] [CrossRef]
- García, M.; Carrasco García, A.; Weigel, W.; Christ, W.; Lira-Junior, R.; Wirth, L.; Tauriainen, J.; Maleki, K.; Vanoni, G.; Vaheri, A.; et al. Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferons. PLoS Pathog. 2024, 20, e1012390. [Google Scholar] [CrossRef]
- Tietäväinen, J.; Mäkelä, S.; Huhtala, H.; Pörsti, I.H.; Strandin, T.; Vaheri, A.; Mustonen, J. The clinical presentation of Puumala hantavirus induced hemorrhagic fever with renal syndrome is related to plasma glucose concentration. Viruses 2021, 13, 1177. [Google Scholar] [CrossRef] [PubMed]
- Vaheri, A.; Smura, T.; Vauhkonen, H.; Hepojoki, J.; Sironen, T.; Strandin, T.; Tietäväinen, J.; Outinen, T.; Mäkelä, S.; Pörsti, I.; et al. Puumala hantavirus infections show extensive variation in clinical outcome. Viruses 2023, 15, 805. [Google Scholar] [CrossRef] [PubMed]
- Tietäväinen, J.; Laine, O.; Mäkelä, S.; Huhtala, H.; Pörsti, I.; Vaheri, A.; Mustonen, J. ABO and Rhesus blood groups in acute Puumala hantavirus infection. Viruses 2021, 13, 2271. [Google Scholar] [CrossRef] [PubMed]
- Tervo, L.; Outinen, T.; Kiekara, T.; Tietäväinen, J.; Paakkala, A.; Pörsti, I.; Huhtala, H.; Mäkelä, S.; Mustonen, J. The presence of intraperitoneal, retroperitoneal and pleural fluid in acute Puumala hantavirus infection. Infect. Dis. 2023, 55, 207–215. [Google Scholar] [CrossRef]
- Mustonen, J.; Vaheri, A.; Pörsti, I.; Mäkelä, S. Long-term consequences of Puumala hantavirus infection. Viruses 2022, 14, 598. [Google Scholar] [CrossRef]
- Klingström, J.; Granath, F.; Ekbom, A.; Björkström, N.K.; Ljunggren, H.G. Increased risk for lymphoma following hemorrhagic fever with renal syndrome. Clin. Infect. Dis. 2014, 59, 1130–1132. [Google Scholar] [CrossRef]
- Yi, Y.J.; Kang, M.; Kim, W.K.; Huh, K.; Klingström, J.; Song, J.W.; Jung, J. Association between haemorrhagic fever with renal syndrome and cancers. Int. J. Infect. Dis. 2021, 113, 127–135. [Google Scholar] [CrossRef]
- Kääriäinen, S.; Ollgren, J.; Dub, T.; Laine, O.; Sinisalo, M.; Hepojoki, J.; Strandin, T.; Kekäläinen, E.; Sane, J.; Lyytikäinen, O. Risk of lymphoid malignancies increased after Puumala virus infection in Finland, 2009-2019: A retrospective register-based cohort study. Int. J. Infect. Dis. 2023, 131, 1–6. [Google Scholar] [CrossRef]
- Mustonen, J.; Henttonen, H.; Vaheri, A. Hantavirus Infections among military forces. Mil. Med. 2024, 189, 551–555. [Google Scholar] [CrossRef]
- Wang, Y.X.G.; Voutilainen, L.; Aminikhah, M.; Helle, H.; Huitu, O.; Laakkonen, J.; Lindén, A.; Niemimaa, J.; Sane, J.; Sironen, T.; et al. The impact of wildlife and environmental factors on hantavirus infection in the host and its translation into human risk. Proc. Biol. Sci. 2023, 290, 20222470. [Google Scholar] [CrossRef]
- Malchair, P.; Giol, J.; García, V.; Rodríguez, O.; Ruibal, J.C.; Zarauza, A.; Llopis, F.; Matellán, L.; Bernal, T.; Solís, B.; et al. Three-day Icatibant on top of standard care in patients with coronavirus disease 2019 pneumonia: A randomized, open-label, phase 2, proof-of-concept trial. Clin. Infect. Dis. 2023, 76, 1784–1792. [Google Scholar] [CrossRef] [PubMed]
- Mustonen, J.; Antonen, J.; Vaheri, A. Icatibant in viral infections. Infect. Dis. 2023, 55, 444–445. [Google Scholar] [CrossRef] [PubMed]
- Wei, X.; Li, X.; Song, S.; Wen, X.; Jin, T.; Zhao, C.; Wu, X.; Liu, K.; Shao, Z. Trends and focuses of hantavirus researches: A global bibliometric analysis and visualization from 1980 to 2020. Arch. Public Health 2022, 80, 218. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mustonen, J.; Strandin, T.; Tietäväinen, J.; Pörsti, I.; Mäkelä, S.; Vaheri, A. Hantavirus Research in Finland. Viruses 2024, 16, 1591. https://doi.org/10.3390/v16101591
Mustonen J, Strandin T, Tietäväinen J, Pörsti I, Mäkelä S, Vaheri A. Hantavirus Research in Finland. Viruses. 2024; 16(10):1591. https://doi.org/10.3390/v16101591
Chicago/Turabian StyleMustonen, Jukka, Tomas Strandin, Johanna Tietäväinen, Ilkka Pörsti, Satu Mäkelä, and Antti Vaheri. 2024. "Hantavirus Research in Finland" Viruses 16, no. 10: 1591. https://doi.org/10.3390/v16101591
APA StyleMustonen, J., Strandin, T., Tietäväinen, J., Pörsti, I., Mäkelä, S., & Vaheri, A. (2024). Hantavirus Research in Finland. Viruses, 16(10), 1591. https://doi.org/10.3390/v16101591